Drugs / salvianolate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials · 1 met primary | ||||||
| Phase 4 | NCT03045562 | Jan 2017 → Dec 2018 | ST-elevation myocardial infarction | Green Valley Group of China | Unknown | No outcome recorded |
| Phase 4 | NCT03037047 | May 2016 → Dec 2017 | intermediate coronary syndrome | Green Valley Group of China | Unknown | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT03306550 | Oct 2017 → Apr 2018 | intermediate coronary syndrome | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | salvianolate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03306550 ↗ |